(Q36519198)

14 August 2017

1 reference

title

A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies (English)

1 reference

14 August 2017

1 reference

Adrian Bagust

1

1 reference

14 August 2017

Marc Evans

2

1 reference

14 August 2017

Sophie Beale

3

1 reference

14 August 2017

Philip D Home

4

1 reference

14 August 2017

Andrew S Perry

5

1 reference

14 August 2017

Murray Stewart

6

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

24 Suppl 1

1 reference

14 August 2017

page(s)

5-19

1 reference

Theoretical analysis of the mechanisms of chronic hyperinsulinemia

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Model of complications of NIDDM. I. Model construction and assumptions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

An economic model of the long-term health care burden of Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Are risk factors for conversion to NIDDM similar in high and low risk populations?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

21 January 2018

12 December 2020

Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Diabetic dyslipidaemia and coronary heart disease: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Lipid profile in the severely obese: changes with weight loss after lap-band surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia: implications for diabetes therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Nateglinide therapy for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Archimedes: a new model for simulating health care systems--the mathematical formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Archimedes: a trial-validated model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Validation of the Archimedes Diabetes Model

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624001-00002

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

1 reference

12 December 2020

One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.

1 reference

12 December 2020

Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Impact of obesity in primary hyperlipidemias

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

1 reference

12 December 2020

UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group

1 reference

12 December 2020

Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.

1 reference

12 December 2020

Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)

1 reference

12 December 2020

Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects.

1 reference

12 December 2020

The global diabetes model: user friendly version 3.0.

1 reference

12 December 2020

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

12 December 2020

Combining sulfonylureas and other oral agents

1 reference

12 December 2020

Maturity onset diabetes mellitus: response to intensive dietary management

1 reference

12 December 2020

Outline of a diabetes disease management model: principles and applications

1 reference

12 December 2020

Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes

1 reference

12 December 2020

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

1 reference

12 December 2020

10.2165/00019053-200624001-00002

Identifiers

DOI

0 references

Dimensions Publication ID

1052794248

0 references

1 reference